A Study of GFH312 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication (IC)

Conditions:   Intermittent Claudication;   Peripheral Artery Disease Interventions:   Drug: GFH312;   Other: Placebo Sponsor:   Zhejiang Genfleet Therapeutics Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials